Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: NSAID/breast cancer study

This article was originally published in The Tan Sheet

Executive Summary

NSAID/breast cancer study: Ohio State University study concludes that NSAIDs "may have chemopreventive potential against the development of breast cancer." Researchers, led by Ohio's Randall Harris, screened 1,534 women without breast cancer and 511 women with newly diagnosed breast cancer for NSAID use according to type, frequency of intake and duration of use. The researchers determined that risk declined with increasing NSAID exposure; the greatest risk reduction (40%) coincided with daily intake for five or more years. The study, which was funded by the National Cancer Institute, is published in the March issue of Epidemiology...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel